title: The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
authors.affiliation: Department of Neurology, University of Texas Health Science Center, 8300 Floyd Curl Drive MC#7883, San Antonio, TX 78229 3900, USA. Hartr@uthscsa.edu
authors.forename: Robert G
authors.initials: RG
authors.lastname: Hart
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D000077144:Clopidogrel; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020300:Intracranial Hemorrhages / Q000188:drug therapy; D000077405:Irbesartan; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013777:Tetrazoles / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000925:Anticoagulants; D001713:Biphenyl Compounds; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011720:Pyrazoles; D011728:Pyridones; D013777:Tetrazoles; C522181:apixaban; D000077144:Clopidogrel; D000077405:Irbesartan; D013988:Ticlopidine; D001241:Aspirin